The webinar "ABC Transporters in Multidrug-Resistant Cancer" organized by Cancer Drug Resistance and chaired by Prof. Thomas Litman from the Department of Immunology & Microbiology, the University of Copenhagen, Denmark was held successfully on September 27, 2022.
Seven outstanding international Guest Speakers delivered their excellent speeches and shared their insights on different topics of multidrug-resistant cancer in the webinar.
Speaker 1: Prof. Thomas Litman, Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Denmark.
Topic: The ABC of Multi-drug Resistance
Dr. Michael M. Gottesman, Intramural Research at the National Institutes of Health and the Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, USA.
Topic: Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
Speaker 3: Dr. Anna Seelig, Department of Biophysical Chemistry, Biocenter of the University of Basel, Switzerland.
Topic: A new model for allocrite transport by P-glycoprotein
Speaker 4: Dr. Till Luckenbach, Department of Bioanalytical Ecotoxicology, Helmholtz Centre for Environmental Research - UFZ, Germany.
Topic: Active transport in the context of ADME in the zebrafish embryo
Speaker 5: Dr. Xiaozhuo Chen, Edison Biotechnology Institute, Microbiology Heritage College of Osteopathic Medicine, Biomedical Sciences, Ohio University, USA.
Topic: Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
Speaker 6: Dr. Ian D. Kerr, School of Life Sciences, University of Nottingham, United Kingdom.
Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
Speaker 7: Dr. Antonio Tito Fojo, Columbia University Irving Medical Center, Columbia University, USA.
Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
In the discussion part, speakers and participants had a lively discussion of several interesting questions, which will have a positive impact on the current research on multidrug-resistant cancer.
Cancer Drug Resistance appreciates the Chair Prof. Thomas Litman and all Guest Speakers again for the substantial effort to make this webinar a great success.
Cancer Drug Resistance will hold more webinars and welcome more researchers to join future webinars!
For more wonderful webinars of the journal, please visit: https://cdrjournal.com/journal/webinar.